Literature DB >> 5725224

Enzymatic degradation of C-terminal tetrapeptide amide of gastrin by mammalian tissue extracts.

L Laster, J H Walsh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5725224

Source DB:  PubMed          Journal:  Fed Proc        ISSN： 0014-9446


× No keyword cloud information.
  8 in total

1.  [The inactivation of pentagastrin (ICI 50, 123) by human serum and liver homogenate].

Authors:  H P Seelig; H Linthe; J B Lüdcke; D Plewe; U Müller; H U Wüstling; M Kessler
Journal:  Klin Wochenschr       Date:  1970-09-01

2.  Effect of hepatic transit of gastrin, pentagastrin, and histamine measured by gastric secretion and by assay of hepatic vein blood.

Authors:  J C Thompson; D D Reeder; W D Davidson; A C Charters; W L Brückner; C A Lemmi; J H Miller
Journal:  Ann Surg       Date:  1969-09       Impact factor: 12.969

3.  The half-life of exogenous gastrin in the circulation.

Authors:  E L Blair; Y Farra; D D Richardson; P Steinbok
Journal:  J Physiol       Date:  1970-06       Impact factor: 5.182

4.  Development of new lipophilic derivatives of tetragastrin: physicochemical characteristics and intestinal absorption of acyl-tetragastrin derivatives in rats.

Authors:  T Tenma; E Yodoya; S Tashima; T Fujita; M Murakami; A Yamamoto; S Muranishi
Journal:  Pharm Res       Date:  1993-10       Impact factor: 4.200

5.  Inactivation of cholecystokinin octapeptide by normal and cirrhotic liver in rats.

Authors:  Z Berger; A Pap; I Ungi; V Varró
Journal:  Int J Pancreatol       Date:  1986-10

6.  Enzymatic inactivation of peptide hormones possessing a C-terminal amide group.

Authors:  J D Glass; I L Schwartz; R Walter
Journal:  Proc Natl Acad Sci U S A       Date:  1969-08       Impact factor: 11.205

7.  Permeability characteristics of tetragastrins across intestinal membranes using the Caco-2 monolayer system: comparison between acylation and application of protease inhibitors.

Authors:  T Fujita; I Kawahara; Y Quan; K Hattori; K Takenaka; S Muranishi; A Yamamoto
Journal:  Pharm Res       Date:  1998-09       Impact factor: 4.200

8.  Comparison of hepatic elimination of different forms of cholecystokinin in dogs. Bioassay and radioimmunoassay comparisons of cholecystokinin-8-sulfate and -33-sulfate.

Authors:  T Sakamoto; M Fujimura; J Newman; X G Zhu; G H Greeley; J C Thompson
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.